OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled trial with an open‐label long‐term extension study

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2011.01460.x
Authors: K. Kaku, T. Itayasu, S. Hiroi, M. Hirayama, Y. Seino
Institutions: Kawasaki Medical School, Takeda (Japan), Kansai Electric Power (Japan), Kansai Electric Power Hospital
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: alogliptin, pioglitazone, type 2 diabetes, adjunctive therapy, DPP-4 inhibitors, sulfonylureas, glycemic control, HbA1c, hypoglycemia, body weight, Japanese patients, long-term extension study, drug safety and tolerability, fasting and postprandial glucose
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2092918268
FWCI: 6.765
Cites: 38
Cited by: 89
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security